Film Television Auditions – Lifestyle
Author:
Zenas BioPharma
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 17, 2026
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million
March 27, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 16, 2026
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 16, 2026